Lunai Bioworks Inc. Stock Issued During Period, Value, Issued for Services
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for the quarter ending 2020-12-31 was $27.90K, a 80.63% decline year-over-year.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for the quarter ending 2020-06-30 was $0.00.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for the quarter ending 2020-03-31 was $144.00K.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for fiscal 2020 was $144.00K, a 260.00% increase from fiscal 2019.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for fiscal 2019 was $40.00K, a 61.90% decline from fiscal 2018.
- Lunai Bioworks Inc. stock issued during period, value, issued for services for fiscal 2018 was $105.00K.
| Period end | Stock Issued During Period, Value, Issued for Services 3 month | Stock Issued During Period, Value, Issued for Services 12 month |
|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $27.90K 10-Q · filed 2021-02-16 | |
| 2020-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $144.00K 10-K · filed 2020-09-23 |
| 2020-03-31 | $144.00K 10-Q · filed 2021-05-17 | $288.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $144.00K 10-Q · filed 2021-02-16 | $144.00K derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-13 | $0.00 derived: sum of 4 quarters · filed 2020-09-23 |
| 2019-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | $40.00K 10-K · filed 2020-09-23 |
| 2019-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | |
| 2018-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-10 | |
| 2018-09-30 | $40.00K 10-Q · filed 2020-02-10 | |
| 2018-06-30 | $105.00K 10-K · filed 2019-09-30 | |
| 2018-03-31 | $105.00K 10-Q · filed 2019-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |